We are live on ! Find out more
MMX

MV Management XI Portfolio holdings

AUM $60.1M
1-Year Est. Return 58.45%
This Fund
S&P 500
This Quarter Est. Return
+24.97%
1 Year Est. Return
+58.45%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$60.1M
AUM Growth
+$2.96M
Cap. Flow
-$11.8M
Cap. Flow %
-19.63%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RXRX icon
Recursion Pharmaceuticals
RXRX
+$11.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 89.96%
2 Healthcare 10.04%
3 Communication Services 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROVR
1
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$54.1M 89.96%
8,638,513
– –
RXRX icon
2
Recursion Pharmaceuticals
RXRX
$1.59B
$6.03M 10.04%
788,762
-1,183,146
-60% -$11.8M
ANGI icon
3
Angi Inc
ANGI
$229M
$3.76K 0.01%
190
– –

Similar funds

OCA
Offit Capital Advisors New York $60.1M AUM 5.62% 1-Year Est. Return
NCM
Nine27 Capital Management New York $60.2M AUM 16.09% 1-Year Est. Return
BHIC
Bassett Hargrove Investment Counsel Greenville, Delaware $59.6M AUM 29.88% 1-Year Est. Return
FWA
Freedom Wealth Alliance Brookfield, Wisconsin $60.8M AUM 14.42% 1-Year Est. Return
SCC
Steel Canyon Capital Phoenix, Arizona $58.4M AUM 22.92% 1-Year Est. Return
KDA
KPCB DGF Associates Menlo Park, California $58.3M AUM 27.35% 1-Year Est. Return
AF
Ardian France Paris, France $62.5M AUM 19.37% 1-Year Est. Return
CFAM
Coury Firm Asset Management Pittsburgh, Pennsylvania $62.6M AUM 16.77% 1-Year Est. Return

MV Management XI's Q3 2023 Portfolio in Review

As of Q3 2023, MV Management XI held 3 positions worth $60.1M, up 5.2% from $57.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

MV Management XI withdrew a net $11.8M in Q3 2023, reducing 1 holding. Its largest reduction was Recursion Pharmaceuticals, cutting an estimated $11.8M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 90% of assets, up from 74% a quarter earlier, followed by Healthcare and Communication Services.

  • MV Management XI's biggest Q3 2023 reduction was Recursion Pharmaceuticals, cutting an estimated $11.8M.
  • MV Management XI's ten largest holdings make up 100% of its $60.1M portfolio in Q3 2023.
  • MV Management XI opened 0 new positions and closed 0 in Q3 2023.
  • MV Management XI's portfolio value rose 5.2% quarter-over-quarter to $60.1M.

Based on MV Management XI's 13F filing for Q3 2023, filed 14 Nov 2023.